Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP85180.RAwFP2ylbm5bgLFGgy4nQ33UOhuPjtZ9EJgOsQBB4rvPo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP85180.RAwFP2ylbm5bgLFGgy4nQ33UOhuPjtZ9EJgOsQBB4rvPo130_assertion type Assertion NP85180.RAwFP2ylbm5bgLFGgy4nQ33UOhuPjtZ9EJgOsQBB4rvPo130_head.
- NP85180.RAwFP2ylbm5bgLFGgy4nQ33UOhuPjtZ9EJgOsQBB4rvPo130_assertion description "[A stratified analysis by menopausal status indicated the association between the NAT2 SNP (rs1799930) and breast cancer was mainly evident in premenopausal women (OR 2.70, 95% CI 1.20-6.07), while the MTRR SNP (rs162049) was significant in postmenopausal women (OR 1.61, 95% CI 1.07-2.44).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP85180.RAwFP2ylbm5bgLFGgy4nQ33UOhuPjtZ9EJgOsQBB4rvPo130_provenance.
- NP85180.RAwFP2ylbm5bgLFGgy4nQ33UOhuPjtZ9EJgOsQBB4rvPo130_assertion evidence source_evidence_literature NP85180.RAwFP2ylbm5bgLFGgy4nQ33UOhuPjtZ9EJgOsQBB4rvPo130_provenance.
- NP85180.RAwFP2ylbm5bgLFGgy4nQ33UOhuPjtZ9EJgOsQBB4rvPo130_assertion SIO_000772 20180013 NP85180.RAwFP2ylbm5bgLFGgy4nQ33UOhuPjtZ9EJgOsQBB4rvPo130_provenance.
- NP85180.RAwFP2ylbm5bgLFGgy4nQ33UOhuPjtZ9EJgOsQBB4rvPo130_assertion wasDerivedFrom gad-20150221 NP85180.RAwFP2ylbm5bgLFGgy4nQ33UOhuPjtZ9EJgOsQBB4rvPo130_provenance.
- NP85180.RAwFP2ylbm5bgLFGgy4nQ33UOhuPjtZ9EJgOsQBB4rvPo130_assertion wasGeneratedBy ECO_0000203 NP85180.RAwFP2ylbm5bgLFGgy4nQ33UOhuPjtZ9EJgOsQBB4rvPo130_provenance.